Tag: BBV154

Source: PIB Contents1 What is the News?2 About BBV154:3 About Mission COVID Suraksha 4 About BIRAC What is the News? BBV154, the first Nasal Vaccine against Covid-19 has received the regulator’s nod for conducting Phase 2 and 3 clinical trials. About BBV154: BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. It is the first… Continue reading First Nasal Vaccine Developed by Bharat Biotech supported by DBT-BIRAC gets nod of regulator for Phase 2 Trial